# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-267453
Filing Date
2025-11-06
Accepted
2025-11-05 18:47:23
Documents
65
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acad-20250930.htm iXBRL | 10-Q | 2325319
2 | EX-31.1 | acad-ex31_1.htm | EX-31.1 | 11985
3 | EX-31.2 | acad-ex31_2.htm | EX-31.2 | 12141
4 | EX-32.1 | acad-ex32_1.htm | EX-32.1 | 8784
5 | EX-32.2 | acad-ex32_2.htm | EX-32.2 | 8830
| Complete submission text file | 0001193125-25-267453.txt |  | 9274021

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | acad-20250930.xsd | EX-101.SCH | 975545
68 | EXTRACTED XBRL INSTANCE DOCUMENT | acad-20250930_htm.xml | XML | 1944296

Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 251455502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)